Schizophrenia is considered a chronic long-term debilitating condition, affecting about 1% of the population. There has been considerable debate about which of the anti-psychotic medications are the best treatments. The debate has usually been structured around typical (older) and atypical (newer) anti-psychotic medications. The revised NICE guidelines (2009) moved towards a more neutral stance between atypical (newer drugs) and typical (older drugs) anti-psychotics.
Methods
This aimed to compare fifteen antipsychotic drugs across seven domains including effectiveness/efficacy (symptom reduction PSYRATS or BPRS), and all cause discontinuation, side effects including Extrapyramidal Side Effects (EPSE), weight gain, prolactin increase, QTc prolongation, and sedation. The authors conducted a Bayesian-framework, multiple treatment meta-analysis.
Results
- 212 trials containing 43,209 participants were identified, 144 (68%) had been conducted by the pharmaceutical industry.
- All drugs included in the analysis fared better than placebo.
- There were high rates of withdrawal across all the studies at about 35%.
- No one drug was best across all the domains – see summary table of best/worst performers across the domains.
- Five atypical anti-psychotics had significantly more EPSE than placebo.
- Efficacy (symptom change) – the best performers were Clozapine, Amisulpride & Olanzapine, the worst performers were Asenapine, Lurasidone & Iloperidone.
- All cause discontinuation – the best performers were Amisulpride, Olanzapine & Clozapine, the worst performers were Lurasidone, Sertindole & Haloperidol.
- EPSE – the best performers were Clozapine, Sertindole & Olanzapine, the worst performers Chlorpromazine, Zotepine & Haloperidol.
- Weight gain – the best performers were Haloperidol, Ziprasidone & Lurasidone, the worst performers Clozapine, Zotepine & Olanzapine.
- Prolactin increase* – the best performers were Aripiprazole, Quetiapine & Asenapine, the worst performers were Haloperidol, Risperidone & Paliperidone.
- QTc prolongation** – the best performers were Lurasidone, Aripirazole & Paliperidone, the worst performers were Ziprasidone, Amisulpride & Sertindole.
- Sedation – the best performers were Amisulpride, Paliperidone & Sertindole, the worst performers were Chlorpromazine, Zotepine & Clozapine.
*Not applicable Amisulpride Clozapine Zotepine, **Not applicable Clozapine Chlopromazine Zotepine
Authors conclusions:
‘Results for our primary outcome challenge the dogma that the efficiency of all antipsychotic drugs is the same.’
‘Antipsychotics differed substantially in side-effects and small but robust differences were seen in efficacy. Our findings challenge the straightforward classification of antipsychotics into first-generation and second-generation groupings. Rather, hierarchies in the different domains should help clinicians to adapt the choice of antipsychotic drug to the needs of individual patients.’
Discussion
It’s interesting to note the differences between the anti-psychotics which might help to challenge some clinician’s beliefs that certain drugs (atypicals) are better than others despite evidence to the contrary (see here). There is clearly a need for a more individualised approach to prescribing which involves negotiation and cost-benefit analysis for each individual service user/patient taking into account the potential side effect profiles and benefits of each drug. The authors suggested that cost appears to becoming a less issue, although atypical anti-psychotics are more expensive especially when new to the market.
Dosing still appears key, although this is not really clear from this review, often trials which compare atypicals with typical anti-psychotics use typical doses above the 7.5 mg Haloperidol or less recommended for treatment of acute psychosis (see here). Some side effects are dose dependent. Further analysis needs to factor this in.
There were some limitations with the review some drugs are not currently used in the UK, others have a good evidence base underpinning them but not included in the analysis, for example, sulpiride and perphenazine. There were some potential problems with the analysis, for example, the use of all cause discontinuation as a proxy measure of acceptability.
Links
Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel R, Geddes J, Kissling W, Stapf M, Lassig B, Salanti G, Davis J (2013) Comparative efficacy and tolerability of 15 anti-psychotic drugs in schizophrenia: a multiple-treatments meta-analysis. The Lancet, Early Online Publication, 27 June 2013
Nina
3 years agoNew Zealand
4 years agoAlison Seymour
5 years agoStephen Whyte
7 years agoGracie Brooks
7 years agoS. Samaddar
8 years agoKathy Baker
8 years agoArmin Luthi
8 years agoAntipsychotics effectiveness measured by an observational study
9 years agobalu
9 years agoWhat do you want from your psychiatric medication?
10 years agoBiological pathways, antipsychotics and schizophrenia
10 years agoBerniceTigheRD
11 years agoSameiHuda
11 years agoEPAKneurologg
11 years agodallsop
11 years agoBlondenanja
11 years agoMental_Elf
11 years agoHelge Ha
11 years ago'Sue Mario
11 years agoMia Yeoman
11 years agoGary Rockach
11 years agoMary Nettle
12 years agotiredlegs
12 years agoSempleSemple
12 years ago121Therapy
12 years agodr_know
12 years agoyobluemama2
12 years agoPsychVictim
12 years agoThe Mental Elf
12 years agoMental_Elf
12 years agoGary Rockach
12 years agoSysnetCardiff
12 years agodrseanmullen
12 years agoNHFTNHSLibrary
12 years agopmreid86
12 years agoMHLonline
12 years agonetworkautism
12 years agoaghoury79
12 years agoCWJ32
12 years agoJohnBaker_UoM
12 years agoRobStamatakis
12 years agoEricaEassom
12 years agodrjameswalters
12 years agoRach4000
12 years agoSherworld86
12 years ago444blackcat
12 years agoannaburhouse
12 years agoSusanDMunro
12 years agosukhdipjhaj
12 years agoBerkeleyBrett
12 years agoMental_Elf
12 years agoLizHughesDD
12 years agoDocArnica
12 years agogregciggsStNLD
12 years agogregciggsStNLD
12 years agoSchrebersSister
12 years agowaltercolor
12 years agoMental_Elf
12 years agoangliacounsel
12 years agoAlisonF101
12 years agoHHLibService
12 years agojoguy1967
12 years agoCraigmclaugh
12 years agoMental_Elf
12 years agoNikki Cumiskey
12 years agoMia Yeoman
12 years agoAndy54321
12 years agoHelge Ha
12 years ago'Sue Mario
12 years agoWLCarersCentre
12 years agosamirshah
12 years agotigerloun
12 years agoCraigmclaugh
12 years agoSaz-q Denny-qq
12 years agoMental_Elf
12 years agoalpacaaddict
12 years agosourcecodeman
12 years agoMichelle Louise Parfitt
12 years agoanyonecandie
12 years agoaghoury79
12 years agohelge
12 years agoCBellenis
12 years agorobbask
12 years agoWill Convery
12 years ago